Description
Evorel Conti: HRT for Managing Menopausal Symptoms
What is Evorel Conti?
Evorel Conti is a combined hormone replacement therapy (HRT) patch used to relieve symptoms associated with menopause. It delivers two hormones — estradiol (a form of oestrogen) and norethisterone acetate (a progestogen) — through the skin. Each patch releases a controlled dose of hormones daily, helping manage menopausal symptoms in women who are post‑menopausal (typically those who haven’t had a period for over a year).
How Evorel Conti Works
Evorel Conti provides continuous combined HRT, meaning both hormones are delivered daily without a break. This helps stabilise hormone levels and reduce menopausal symptoms. The transdermal (patch) route allows the hormones to be absorbed through the skin, bypassing the liver and potentially reducing some risks associated with oral HRT.
Benefits of Evorel Conti
- Relief from vasomotor symptoms such as hot flashes and night sweats.
- Improved mood and sleep quality, often disrupted during menopause.
- Protection against bone loss, reducing the risk of osteoporosis.
- Reduced risk of endometrial hyperplasia (thickening of the uterine lining) compared with oestrogen‑only therapy, thanks to the added progestogen.
Common Side Effects
Many users experience minor side effects that may fade over time as the body adjusts:
- Skin irritation, redness, or itching at the patch site
- Headache, nausea, or gastrointestinal changes such as diarrhoea
- Breast tenderness or pain
- Fatigue or mood changes
- Irregular bleeding or spotting during the early months of use
It is important to contact our healthcare professionals if side effects are severe, persistent, or concerning.
Risks and Serious Considerations
Although Evorel Conti is generally well tolerated, HRT carries some important risks that should be discussed with a clinician:
Potential Risks
- Breast cancer risk: Combined HRT may slightly increase the risk when used long-term.
- Blood clots: Oestrogen-containing HRT can increase the risk, especially in the first year.
- Stroke and heart disease: There may be a slight increased risk for certain users.
- Liver issues: Rare, but liver function should be monitored if symptoms appear.
Cautions and Contraindications
Evorel Conti should not be used if any of the following apply:
- Current, past, or suspected breast cancer or other oestrogen-dependent cancers
- Unexplained vaginal bleeding
- History of blood clots or clotting disorders
- Liver disease or impaired liver function
- Known or suspected porphyria (a rare blood disorder)
- Pregnancy or breastfeeding
Additionally, conditions such as gallstones, migraines, high blood pressure, diabetes, asthma, or a family history of hormone-related cancers may require careful monitoring.
Reviews
There are no reviews yet.